Pharmacist-Led Interventions in Public Health: A Global Perspective

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Medication Management".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 1965

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA
Interests: social & administrative pharmacy; chronic conditions; pharmacy practice; opioid crisis

E-Mail Website
Guest Editor
Department of Clinical Pharmacy and Translational Science, College of Pharmacy, The University of Tennessee Health Science Center, Nashville, TN 37211, USA
Interests: healthcare; qualitative research; HIV/AIDS; psychology; public health

Special Issue Information

Dear Colleagues,

Globally, pharmacists remain one of the most accessible health professionals. Due to their clinical knowledge, pharmacists are well-positioned to enhance their scope of practice through the public health lens by caring for patients and initiating interventions. This Special Issue in Pharmacist-Led Interventions in Public Health: a global perspective is focused on the broad spectrum of public health, including prevention studies such as pre-exposure prophylaxis (PrEP) and post-exposure treatment (PEP), vaccine, vaccine hesitancy, pharmacy driven studies conducted in rural or urban areas, collaborative practice agreement studies. We look forward to receiving your submissions describing pharmacists' role to enhance their visibility in public health by optimizing patient care in the community setting.

To of interest include but are not limited to the following:

  • Original research
  • Protocols to develop intervention studies
  • Commentary and opinion manuscripts
  • Literature reviews, including rapid, Scopus, and systematic literature reviews
  • Interdisciplinary collaboration in public health
  • The role of technology in public health, including artificial intelligence
  • Interventions in community-based pharmacy
  • Population health interventions across the pharmacy practice settings
  • Education and training of public health professionals

Dr. David Rhys Axon
Dr. Alina Cernasev
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • public health
  • prevention
  • interdisciplinary team
  • COVID-19 vaccination
  • community pharmacy interventions

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

10 pages, 222 KiB  
Article
Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee
by Alina Cernasev, Oluwafemifola Oyedeji, Cary M. Springer, Tracy M. Hagemann, Kenneth C. Hohmeier and Kristina W. Kintziger
Healthcare 2024, 12(13), 1305; https://doi.org/10.3390/healthcare12131305 - 29 Jun 2024
Viewed by 584
Abstract
HPV is the most prevalent sexually transmitted infection in the U.S., with more than 80% of all Americans contracting it by age 45. Effective vaccines for HPV exist and were recently approved for adults aged 27–45 years, though uptake remains low in all [...] Read more.
HPV is the most prevalent sexually transmitted infection in the U.S., with more than 80% of all Americans contracting it by age 45. Effective vaccines for HPV exist and were recently approved for adults aged 27–45 years, though uptake remains low in all age groups, particularly in Tennessee where 1089 cancers were attributed to HPV in 2020. Between 29 June and 17 August 2023, we conducted a cross-sectional survey to gain insights about the barriers and facilitators of HPV in 2011 adults aged 18 to 45 years in Tennessee. We developed our survey based on previous instruments to understand predictors of HPV vaccination in adults. Using descriptive statistics and bivariate and logistic regression analyses, we found higher vaccination rates in females, participants aged 18–38 years, participants with a high school education or higher, Hispanic or Latine individuals, and participants identifying as moderate or liberal. These insights highlight the need for public health interventions that consider demographic differences to successfully increase vaccination rates and reduce HPV-associated cancer risk. Full article
(This article belongs to the Special Issue Pharmacist-Led Interventions in Public Health: A Global Perspective)

Review

Jump to: Research

25 pages, 1194 KiB  
Review
Pharmacists’ Role in Global TB Elimination: Practices, Pitfalls, and Potential
by Alina Cernasev, Jonathan Stillo, Jolie Black, Mythili Batchu, Elaina Bell and Cynthia A. Tschampl
Healthcare 2024, 12(11), 1137; https://doi.org/10.3390/healthcare12111137 - 3 Jun 2024
Viewed by 716
Abstract
Tuberculosis (TB) is the top infectious killer in the world despite efforts to eliminate it. Pharmaceutical care roles are pillars of pharmacy practice, and pharmacists are well equipped to serve a unique role in the pathway to provide education about TB. Previous systematic [...] Read more.
Tuberculosis (TB) is the top infectious killer in the world despite efforts to eliminate it. Pharmaceutical care roles are pillars of pharmacy practice, and pharmacists are well equipped to serve a unique role in the pathway to provide education about TB. Previous systematic reviews emphasize pharmacists’ role in treating TB; however, pharmacists can and do play much broader roles in overall TB elimination efforts. Five researchers searched five electronic databases (PubMed, PsychInfo, CINAHL, Academic Search Premier, and Embase). Search terms included pharmacy, pharmacist, tuberculosis, antitubercular agents, supply, distribution, and drug therapy. Inclusion criteria were studies published from 2010 through March 2023, in English or Spanish, addressed a specific TB-related role for pharmacists/pharmacies, and were peer-reviewed. Exclusion criteria included pharmacology, pharmacokinetics, clinical trials on drug efficacy, and editorials. Two researchers conducted each level of review; for discordance, a third researcher reviewed, and a decision was reached by consensus. Roles were extracted and cross-referenced with traditional pharmaceutical care steps. Of the initial 682 hits, 133 were duplicates. After further review, we excluded 514 records, leaving 37 articles for full extraction. We found nine roles for pharmacists in TB prevention and classified them as implemented, not implemented, or recommended. These roles were: (1) TB symptom screening; (2) Referring to TB care systems; (3) TB testing; (4) Dispensing TB medication correctly and/or directly observed therapy; (5) Counseling; (6) Looking to reduce socioeconomic barriers; (7) Procurement of TB medications; (8) Quality assurance of TB medications; (9) Maintaining and using pharmacy data systems. Pharmacists are well situated to play a vital role in the global fight against TB. Findings suggested pharmacists in many settings have already expanded their roles related to TB elimination beyond traditional pharmaceutical care. Still others need to increase the understanding of TB procurement and treatment, their power to improve TB care, and their contributions to data systems that serve population health. Pharmacy curricula should increase TB-related training to better equip future pharmacists to contribute to TB elimination. Full article
(This article belongs to the Special Issue Pharmacist-Led Interventions in Public Health: A Global Perspective)
Show Figures

Figure 1

Back to TopTop